FY2020 EPS Estimates for Henry Schein, Inc. (HSIC) Decreased by Gabelli
Henry Schein, Inc. (NASDAQ:HSIC) – Equities research analysts at Gabelli cut their FY2020 earnings per share (EPS) estimates for Henry Schein in a note issued to investors on Tuesday. Gabelli analyst K. Kedra now anticipates that the company will earn $4.85 per share for the year, down from their previous estimate of $5.00.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Monday, November 6th. The company reported $0.87 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.90 by ($0.03). Henry Schein had a return on equity of 19.71% and a net margin of 4.52%. The firm had revenue of $3.16 billion for the quarter, compared to the consensus estimate of $3.05 billion. During the same period in the previous year, the company posted $0.84 EPS. Henry Schein’s quarterly revenue was up 10.3% compared to the same quarter last year.
Other equities research analysts also recently issued research reports about the company. Jefferies Group LLC reaffirmed a “hold” rating and set a $88.50 price objective on shares of Henry Schein in a research report on Friday, July 21st. Piper Jaffray Companies raised Henry Schein from a “neutral” rating to an “overweight” rating in a research report on Friday, September 15th. TheStreet downgraded Henry Schein from a “b” rating to a “c+” rating in a research report on Monday. Royal Bank Of Canada began coverage on Henry Schein in a research report on Tuesday, September 19th. They set a “sector perform” rating and a $91.00 price objective on the stock. Finally, Zacks Investment Research downgraded Henry Schein from a “buy” rating to a “hold” rating in a research report on Wednesday, August 9th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and seven have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $89.88.
Shares of Henry Schein (NASDAQ:HSIC) traded down $2.61 during mid-day trading on Thursday, reaching $67.05. The company had a trading volume of 5,070,260 shares, compared to its average volume of 1,106,182. Henry Schein has a 12 month low of $67.02 and a 12 month high of $93.50. The company has a market capitalization of $10,730.00, a P/E ratio of 19.64, a P/E/G ratio of 1.90 and a beta of 1.03. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.85 and a current ratio of 1.55.
Large investors have recently made changes to their positions in the company. YorkBridge Wealth Partners LLC raised its position in Henry Schein by 5.2% during the second quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock valued at $104,000 after acquiring an additional 28 shares in the last quarter. Sun Life Financial INC raised its position in Henry Schein by 8,185.7% during the second quarter. Sun Life Financial INC now owns 580 shares of the company’s stock valued at $106,000 after acquiring an additional 573 shares in the last quarter. FTB Advisors Inc. raised its position in Henry Schein by 100.0% during the third quarter. FTB Advisors Inc. now owns 1,484 shares of the company’s stock valued at $120,000 after acquiring an additional 742 shares in the last quarter. Trust Co. of Vermont raised its position in Henry Schein by 56.7% during the third quarter. Trust Co. of Vermont now owns 1,702 shares of the company’s stock valued at $140,000 after acquiring an additional 616 shares in the last quarter. Finally, Lee Financial Co raised its position in Henry Schein by 100.0% during the third quarter. Lee Financial Co now owns 1,756 shares of the company’s stock valued at $144,000 after acquiring an additional 878 shares in the last quarter. Hedge funds and other institutional investors own 48.16% of the company’s stock.
In other news, SVP Paul Rose sold 2,126 shares of the firm’s stock in a transaction dated Wednesday, September 6th. The stock was sold at an average price of $172.51, for a total value of $366,756.26. Following the completion of the transaction, the senior vice president now directly owns 17,841 shares in the company, valued at $3,077,750.91. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 1.19% of the company’s stock.
Henry Schein declared that its Board of Directors has authorized a stock repurchase plan on Monday, September 18th that authorizes the company to buyback $400.00 million in shares. This buyback authorization authorizes the company to purchase up to 6.3% of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s management believes its shares are undervalued.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.